[
  {
    "title": "嘉应制药(002198.SZ)：第一大股东老虎汇所持5720万股的司法拍卖已流拍",
    "href": "http://stock.jrj.com.cn/2022/12/02193037185520.shtml",
    "datetime": "2022-12-02 19:30:36",
    "code": "002198"
  },
  {
    "title": "前两大股东都要撤了！“无主”嘉应制药前三季业绩增长又是昙花一现？",
    "href": "http://stock.jrj.com.cn/2022/11/02083237105475.shtml",
    "datetime": "2022-11-02 08:32:00",
    "code": "002198"
  },
  {
    "title": "嘉应制药：股东陈少彬拟减持不超2.5%",
    "href": "http://stock.jrj.com.cn/2022/10/31155637099794.shtml",
    "datetime": "2022-10-31 15:56:17",
    "code": "002198"
  },
  {
    "title": "嘉应制药(002198.SZ)：持股10.01%股东陈少彬拟减持不超2.5%股份",
    "href": "http://stock.jrj.com.cn/2022/10/31155537099802.shtml",
    "datetime": "2022-10-31 15:55:32",
    "code": "002198"
  },
  {
    "title": "嘉应制药(002198.SZ)：朱拉伊辞去总经理职务",
    "href": "http://stock.jrj.com.cn/2022/09/14165636994371.shtml",
    "datetime": "2022-09-14 16:56:52",
    "code": "002198"
  },
  {
    "title": "嘉应制药(002198.SZ)上半年净利859.47万元，同比增长105.33%",
    "href": "http://stock.jrj.com.cn/2022/08/19183036917302.shtml",
    "datetime": "2022-08-19 18:30:10",
    "code": "002198"
  },
  {
    "title": "嘉应制药2022年第一季度净利253.57万同比下滑67.34% 营业总成本增加",
    "href": "http://stock.jrj.com.cn/2022/05/03115036541851.shtml",
    "datetime": "2022-05-03 11:50:39",
    "code": "002198"
  },
  {
    "title": "嘉应制药(002198.SZ)一季度净利润253.57万元 同比下降67.34%",
    "href": "http://stock.jrj.com.cn/2022/04/26160436475730.shtml",
    "datetime": "2022-04-26 16:04:02",
    "code": "002198"
  },
  {
    "title": "嘉应制药(002198.SZ)：拟终止2021年度非公开发行A股股票事项",
    "href": "http://stock.jrj.com.cn/2022/04/08174236273211.shtml",
    "datetime": "2022-04-08 17:42:41",
    "code": "002198"
  },
  {
    "title": "嘉应制药2021年净利147.73万同比下滑92.55% 董事长朱拉伊薪酬5万",
    "href": "http://stock.jrj.com.cn/2022/03/11222834816006.shtml",
    "datetime": "2022-03-11 22:28:43",
    "code": "002198"
  },
  {
    "title": "嘉应制药(002198.SZ)2021年度净利润147.73万元 同比下降92.55%",
    "href": "http://stock.jrj.com.cn/2022/03/11190934815170.shtml",
    "datetime": "2022-03-11 19:09:03",
    "code": "002198"
  },
  {
    "title": "嘉应制药(002198.SZ)：全资子公司中标4000万元兴宁市人民医院异地(整体)搬迁新建项目医疗设备采购项目",
    "href": "http://stock.jrj.com.cn/2022/01/14170834158117.shtml",
    "datetime": "2022-01-14 17:08:30",
    "code": "002198"
  },
  {
    "title": "嘉应制药(002198.SZ)：聘请西南证券为保荐机构",
    "href": "http://stock.jrj.com.cn/2021/11/22174333904533.shtml",
    "datetime": "2021-11-22 17:43:11",
    "code": "002198"
  },
  {
    "title": "嘉应制药：罢免徐胜利、肖义南两董事议案获股东大会通过",
    "href": "http://stock.jrj.com.cn/2021/11/16213933862067.shtml",
    "datetime": "2021-11-16 21:39:29",
    "code": "002198"
  },
  {
    "title": "老虎汇称罢免董事实属被迫 嘉应制药或因内斗被ST",
    "href": "http://stock.jrj.com.cn/2021/11/12090533839758.shtml",
    "datetime": "2021-11-12 09:05:47",
    "code": "002198"
  },
  {
    "title": "嘉应制药(002198.SZ)：黄智勇和黄利兵协议转让5.03%的股份予刘理彪已完成过户",
    "href": "http://stock.jrj.com.cn/2021/11/09185133828568.shtml",
    "datetime": "2021-11-09 18:51:47",
    "code": "002198"
  },
  {
    "title": "嘉应制药(002198.SZ)：陈泳洪协议转让10.01%的股份予陈少彬已完成过户",
    "href": "http://stock.jrj.com.cn/2021/11/09184533828499.shtml",
    "datetime": "2021-11-09 18:45:28",
    "code": "002198"
  },
  {
    "title": "董事会席位争夺战正式打响 嘉应制药两方5名董事被提请罢免",
    "href": "http://stock.jrj.com.cn/2021/11/05082133815541.shtml",
    "datetime": "2021-11-05 08:21:20",
    "code": "002198"
  },
  {
    "title": "管理层内斗愈演愈烈 大股东终止减持 “佛系”嘉应制药业绩低迷依旧",
    "href": "http://stock.jrj.com.cn/2021/11/05081333815839.shtml",
    "datetime": "2021-11-05 08:13:00",
    "code": "002198"
  },
  {
    "title": "“史诗级”内斗！这只A股，又有董事被提请罢免，网友：鱼死网破？",
    "href": "http://stock.jrj.com.cn/2021/11/04122233812028.shtml",
    "datetime": "2021-11-04 12:22:25",
    "code": "002198"
  },
  {
    "title": "嘉应制药股权争夺战狼烟再起 新进股东提请罢免两董事",
    "href": "http://stock.jrj.com.cn/2021/11/03084833806784.shtml",
    "datetime": "2021-11-03 08:48:40",
    "code": "002198"
  },
  {
    "title": "嘉应制药：多名股东拟合计转让公司15.04%股份",
    "href": "http://stock.jrj.com.cn/2021/11/02221033805114.shtml",
    "datetime": "2021-11-02 22:10:59",
    "code": "002198"
  },
  {
    "title": "嘉应制药(002198.SZ)：陈泳洪等三位股东终止与林少斌的股份转让协议",
    "href": "http://stock.jrj.com.cn/2021/11/02205133804934.shtml",
    "datetime": "2021-11-02 20:51:40",
    "code": "002198"
  },
  {
    "title": "嘉应制药(002198.SZ)：股东陈泳洪提前终止减持计划 已减持476.25万股",
    "href": "http://stock.jrj.com.cn/2021/11/02204733804925.shtml",
    "datetime": "2021-11-02 20:47:55",
    "code": "002198"
  },
  {
    "title": "嘉应制药(002198.SZ)：股东陈泳洪拟协议转让10.01%股份予陈少彬",
    "href": "http://stock.jrj.com.cn/2021/11/02204633804924.shtml",
    "datetime": "2021-11-02 20:46:24",
    "code": "002198"
  },
  {
    "title": "嘉应制药(002198.SZ)：股东黄智勇、黄利兵拟协议转让5.03%股份予刘理彪",
    "href": "http://stock.jrj.com.cn/2021/11/02204433804877.shtml",
    "datetime": "2021-11-02 20:44:25",
    "code": "002198"
  },
  {
    "title": "嘉应制药“全武行”暴露股东之间矛盾，大股东债务压力沉重，资本动作不断",
    "href": "http://stock.jrj.com.cn/2021/10/31151733784693.shtml",
    "datetime": "2021-10-31 15:17:30",
    "code": "002198"
  },
  {
    "title": "“内斗”在升级，公告又出猛料，嘉应制药业绩增18倍，两董事不认可",
    "href": "http://stock.jrj.com.cn/2021/10/27083833759338.shtml",
    "datetime": "2021-10-27 08:38:53",
    "code": "002198"
  },
  {
    "title": "嘉应制药股东内斗再度升级 三季报遭两名董事异议",
    "href": "http://stock.jrj.com.cn/2021/10/27083333759320.shtml",
    "datetime": "2021-10-27 08:33:10",
    "code": "002198"
  },
  {
    "title": "董秘被打、被罢免细节曝光！这家公司董事会吵起来了",
    "href": "http://stock.jrj.com.cn/2021/10/23104033737475.shtml",
    "datetime": "2021-10-23 10:40:20",
    "code": "002198"
  },
  {
    "title": "董秘挨打后又遭解聘 嘉应制药股权之争获监管层关注",
    "href": "http://stock.jrj.com.cn/2021/10/20090533719983.shtml",
    "datetime": "2021-10-20 09:05:59",
    "code": "002198"
  },
  {
    "title": "嘉应制药收关注函：要求说明解聘董事会秘书的理由及充分性",
    "href": "http://stock.jrj.com.cn/2021/10/19202833718031.shtml",
    "datetime": "2021-10-19 20:28:42",
    "code": "002198"
  },
  {
    "title": "嘉应制药收关注函：要求公司说明解聘董事会秘书的理由及充分性",
    "href": "http://stock.jrj.com.cn/2021/10/19163833716720.shtml",
    "datetime": "2021-10-19 16:38:42",
    "code": "002198"
  },
  {
    "title": "董秘被打后又遭解聘！嘉应制药独家回应：肢体冲突是两人私事",
    "href": "http://stock.jrj.com.cn/2021/10/19124133715702.shtml",
    "datetime": "2021-10-19 12:41:40",
    "code": "002198"
  },
  {
    "title": "年度最惨董秘？“被殴打”、吃罚单，又被解聘了",
    "href": "http://stock.jrj.com.cn/2021/10/19122633715678.shtml",
    "datetime": "2021-10-19 12:26:50",
    "code": "002198"
  },
  {
    "title": "嘉应制药解聘徐胜利董秘、副总经理职务",
    "href": "http://stock.jrj.com.cn/2021/10/18203333712592.shtml",
    "datetime": "2021-10-18 20:33:02",
    "code": "002198"
  },
  {
    "title": "嘉应制药(002198.SZ)：拟向银行申请总计不超5亿元综合授信额度",
    "href": "http://stock.jrj.com.cn/2021/10/18201233712493.shtml",
    "datetime": "2021-10-18 20:12:59",
    "code": "002198"
  },
  {
    "title": "嘉应制药(002198.SZ)：聘任冯杰为公司财务总监",
    "href": "http://stock.jrj.com.cn/2021/10/18200833712477.shtml",
    "datetime": "2021-10-18 20:08:34",
    "code": "002198"
  },
  {
    "title": "嘉应制药：决定解聘董事会秘书徐胜利",
    "href": "http://stock.jrj.com.cn/2021/10/18200233712460.shtml",
    "datetime": "2021-10-18 20:02:35",
    "code": "002198"
  },
  {
    "title": "嘉应制药内斗再升级：董秘遭股东关门殴打 信披秘钥曾被抢夺",
    "href": "http://stock.jrj.com.cn/2021/10/16113533701924.shtml",
    "datetime": "2021-10-16 11:35:00",
    "code": "002198"
  },
  {
    "title": "嘉应制药(002198.SZ)前三季度预盈357万–553.2万元 同比扭亏为盈",
    "href": "http://stock.jrj.com.cn/2021/10/14211333693256.shtml",
    "datetime": "2021-10-14 21:13:23",
    "code": "002198"
  },
  {
    "title": "嘉应制药监事赖义财子女短线炒公司股票赚13万元 被出具监管函",
    "href": "http://stock.jrj.com.cn/2021/08/25092633315285.shtml",
    "datetime": "2021-08-25 09:26:38",
    "code": "002198"
  },
  {
    "title": "嘉应制药财务总监陈晓燕辞职 朱拉伊代为履行财务总监职责 上半年公司净利418.58万",
    "href": "http://stock.jrj.com.cn/2021/08/13233833251220.shtml",
    "datetime": "2021-08-13 23:38:32",
    "code": "002198"
  },
  {
    "title": "嘉应制药：上半年营收同比增长21.14% 归母净利润实现扭亏为盈",
    "href": "http://stock.jrj.com.cn/2021/08/13194133250294.shtml",
    "datetime": "2021-08-13 19:41:41",
    "code": "002198"
  },
  {
    "title": "嘉应制药2021年半年度净利418.58万元 同比扭亏为盈",
    "href": "http://stock.jrj.com.cn/2021/08/13184933250020.shtml",
    "datetime": "2021-08-13 18:49:48",
    "code": "002198"
  },
  {
    "title": "嘉应制药(002198.SZ)：财务总监陈晓燕辞职 朱拉伊暂代",
    "href": "http://stock.jrj.com.cn/2021/08/13182333249845.shtml",
    "datetime": "2021-08-13 18:23:06",
    "code": "002198"
  },
  {
    "title": "嘉应制药(002198.SZ)上半年实现净利418.58万元 同比扭亏",
    "href": "http://stock.jrj.com.cn/2021/08/13181933249832.shtml",
    "datetime": "2021-08-13 18:19:27",
    "code": "002198"
  },
  {
    "title": "嘉应制药(002198.SZ)：监事赖义财亲属短线交易公司股票",
    "href": "http://stock.jrj.com.cn/2021/08/10175533232434.shtml",
    "datetime": "2021-08-10 17:55:30",
    "code": "002198"
  },
  {
    "title": "嘉应制药2021年上半年预计净利255万-950万 生产经营正常",
    "href": "http://stock.jrj.com.cn/2021/07/16194733109016.shtml",
    "datetime": "2021-07-16 19:47:36",
    "code": "002198"
  },
  {
    "title": "嘉应制药(002198.SZ)：预计上半年净利255-950万元 同比扭亏为盈",
    "href": "http://stock.jrj.com.cn/2021/07/15204333103491.shtml",
    "datetime": "2021-07-15 20:43:15",
    "code": "002198"
  },
  {
    "title": "【龙虎榜】嘉应制药7月7日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2021/07/07180533059267.shtml",
    "datetime": "2021-07-07 18:05:32",
    "code": "002198"
  },
  {
    "title": "A股异动 | 嘉应制药(002198.SZ)跌逾5% 股东陈泳洪拟减持3.8%股份",
    "href": "http://stock.jrj.com.cn/2021/06/24094432987584.shtml",
    "datetime": "2021-06-24 09:44:55",
    "code": "002198"
  },
  {
    "title": "嘉应制药：持股5%以上股东陈泳洪拟减持不超3.8%公司股份",
    "href": "http://stock.jrj.com.cn/2021/06/23173632983879.shtml",
    "datetime": "2021-06-23 17:36:26",
    "code": "002198"
  },
  {
    "title": "嘉应制药(002198.SZ)：股东陈泳洪拟减持3.8%股份",
    "href": "http://stock.jrj.com.cn/2021/06/23164732983461.shtml",
    "datetime": "2021-06-23 16:47:25",
    "code": "002198"
  },
  {
    "title": "嘉应制药(002198.SZ)：股东陈泳洪、黄利兵被财产保全的股份撤销裁定",
    "href": "http://stock.jrj.com.cn/2021/06/20205132961753.shtml",
    "datetime": "2021-06-20 20:51:55",
    "code": "002198"
  },
  {
    "title": "嘉应制药控制权之争尘埃落定 新南方将成控股股东",
    "href": "http://stock.jrj.com.cn/2021/06/18205532956950.shtml",
    "datetime": "2021-06-18 20:55:00",
    "code": "002198"
  },
  {
    "title": "【龙虎榜】嘉应制药6月18日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2021/06/18180432955636.shtml",
    "datetime": "2021-06-18 18:04:50",
    "code": "002198"
  },
  {
    "title": "嘉应制药(002198.SZ)：实际控制人变更为朱拉伊",
    "href": "http://stock.jrj.com.cn/2021/06/17215032950088.shtml",
    "datetime": "2021-06-17 21:50:17",
    "code": "002198"
  },
  {
    "title": "嘉应制药(002198.SZ)：拟定增募资8.8亿元 用于补充流动资金",
    "href": "http://stock.jrj.com.cn/2021/06/17213232949933.shtml",
    "datetime": "2021-06-17 21:32:01",
    "code": "002198"
  },
  {
    "title": "嘉应制药(002198.SZ)：股份转让及非公开发行股份事项暂缓 明日复牌",
    "href": "http://stock.jrj.com.cn/2021/06/11000232907489.shtml",
    "datetime": "2021-06-11 00:02:24",
    "code": "002198"
  },
  {
    "title": "嘉应制药(002198.SZ)：筹划控制权变更 明起停牌",
    "href": "http://stock.jrj.com.cn/2021/06/03192732870503.shtml",
    "datetime": "2021-06-03 19:27:01",
    "code": "002198"
  },
  {
    "title": "【龙虎榜】嘉应制药5月6日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2021/05/06180632702482.shtml",
    "datetime": "2021-05-06 18:06:50",
    "code": "002198"
  },
  {
    "title": "嘉应制药停牌！股东筹划股份转让，控制权或将变更",
    "href": "http://stock.jrj.com.cn/2021/04/23093432428527.shtml",
    "datetime": "2021-04-23 09:34:19",
    "code": "002198"
  },
  {
    "title": "嘉应制药2020年净利1983.83万 总经理宋稚牛薪酬41.62万",
    "href": "http://stock.jrj.com.cn/2021/04/20150432409611.shtml",
    "datetime": "2021-04-20 15:04:13",
    "code": "002198"
  },
  {
    "title": "嘉应制药(002198.SZ)2020年净利达1983.83万元 同比扭亏为盈",
    "href": "http://stock.jrj.com.cn/2021/04/19232732404880.shtml",
    "datetime": "2021-04-19 23:27:21",
    "code": "002198"
  },
  {
    "title": "嘉应制药(002198.SZ)：推举代会波代为履行董事长职务",
    "href": "http://stock.jrj.com.cn/2021/02/25221332028181.shtml",
    "datetime": "2021-02-25 22:13:46",
    "code": "002198"
  },
  {
    "title": "嘉应制药2020年预计净利1760万-2630万扭亏为盈 费用下降",
    "href": "http://stock.jrj.com.cn/2021/01/29191531811075.shtml",
    "datetime": "2021-01-29 19:15:06",
    "code": "002198"
  },
  {
    "title": "嘉应制药：2020年净利预盈1760万元–2630万元 同比实现扭亏为盈",
    "href": "http://stock.jrj.com.cn/2021/01/29143631808980.shtml",
    "datetime": "2021-01-29 14:36:54",
    "code": "002198"
  },
  {
    "title": "嘉应制药前三季度亏损25.32万 部分高毛利率产品销售占比下滑",
    "href": "http://stock.jrj.com.cn/2020/10/26080431130716.shtml",
    "datetime": "2020-10-26 08:04:21",
    "code": "002198"
  },
  {
    "title": "嘉应制药2020年上半年亏损289.39万由盈转亏 产品原材料成本增加",
    "href": "http://stock.jrj.com.cn/2020/08/31175130644425.shtml",
    "datetime": "2020-08-31 17:51:20",
    "code": "002198"
  },
  {
    "title": "嘉应制药：2020年前三季度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2020/08/30231030624404.shtml",
    "datetime": "2020-08-30 23:10:01",
    "code": "002198"
  },
  {
    "title": "嘉应制药：股东未如期完成增持计划 收到证监局警示函",
    "href": "http://stock.jrj.com.cn/2020/08/07165030450641.shtml",
    "datetime": "2020-08-07 16:50:50",
    "code": "002198"
  },
  {
    "title": "嘉应制药股东中联集信合计增持81万股 耗资约500.73万元",
    "href": "http://stock.jrj.com.cn/2020/07/26205130342096.shtml",
    "datetime": "2020-07-26 20:51:33",
    "code": "002198"
  },
  {
    "title": "嘉应制药：2020年半年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2020/07/15084030246034.shtml",
    "datetime": "2020-07-15 08:40:44",
    "code": "002198"
  },
  {
    "title": "嘉应制药2020年上半年预计亏损0万元–350万元 医药产品销售量出现下滑",
    "href": "http://stock.jrj.com.cn/2020/07/14192130240714.shtml",
    "datetime": "2020-07-14 19:21:41",
    "code": "002198"
  },
  {
    "title": "快讯：嘉应制药急速拉升5.79% 主力资金净流出324.51万元(dev)",
    "href": "http://stock.jrj.com.cn/2020/07/02094130119046.shtml",
    "datetime": "2020-07-02 09:41:36",
    "code": "002198"
  },
  {
    "title": "快讯：嘉应制药急速拉升5.96% 主力资金净流入303.23万元(dev)",
    "href": "http://stock.jrj.com.cn/2020/07/01132330110176.shtml",
    "datetime": "2020-07-01 13:23:00",
    "code": "002198"
  },
  {
    "title": "嘉应制药：第一大股东中联集信原股东陈建宁将其持有的占中联集信50%比例的股权转让给中联集信原股东陈玉生",
    "href": "http://stock.jrj.com.cn/2020/06/23081829995279.shtml",
    "datetime": "2020-06-23 08:18:20",
    "code": "002198"
  },
  {
    "title": "嘉应制药回应2019年财报“非标” ：内控缺陷已整改",
    "href": "http://stock.jrj.com.cn/2020/06/02183929828937.shtml",
    "datetime": "2020-06-02 18:39:58",
    "code": "002198"
  },
  {
    "title": "嘉应制药2019年亏损1.22亿 较上年同期由盈转亏",
    "href": "http://stock.jrj.com.cn/2020/04/26223829379406.shtml",
    "datetime": "2020-04-26 22:38:42",
    "code": "002198"
  },
  {
    "title": "嘉应制药2020年第一季度净利167.4万下滑80.25% 支付银行短期借款利息增加",
    "href": "http://stock.jrj.com.cn/2020/04/26212129378860.shtml",
    "datetime": "2020-04-26 21:21:12",
    "code": "002198"
  },
  {
    "title": "嘉应制药2020年一季度预计净利250万元–375万元 同比下降55.78%-70.52%",
    "href": "http://stock.jrj.com.cn/2020/04/10212329259709.shtml",
    "datetime": "2020-04-10 21:23:19",
    "code": "002198"
  },
  {
    "title": "嘉应制药2019年度亏损1.18亿 部分产品市场断货",
    "href": "http://stock.jrj.com.cn/2020/02/28230728917907.shtml",
    "datetime": "2020-02-28 23:07:41",
    "code": "002198"
  },
  {
    "title": "嘉应制药捐赠105万元抗疫急需物资",
    "href": "http://stock.jrj.com.cn/2020/02/24113328881157.shtml",
    "datetime": "2020-02-24 11:33:02",
    "code": "002198"
  },
  {
    "title": "嘉应制药：捐赠价值105万元急需物资支持疫情抗击",
    "href": "http://stock.jrj.com.cn/2020/02/21191628872944.shtml",
    "datetime": "2020-02-21 19:16:42",
    "code": "002198"
  },
  {
    "title": "嘉应制药：捐赠价值105万元急需物资支持抗击疫情",
    "href": "http://stock.jrj.com.cn/2020/02/21182328872470.shtml",
    "datetime": "2020-02-21 18:23:00",
    "code": "002198"
  },
  {
    "title": "嘉应制药：2019年年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2020/01/23075028725587.shtml",
    "datetime": "2020-01-23 07:50:05",
    "code": "002198"
  },
  {
    "title": "嘉应制药2019年度预计亏损1.13亿元–1.42亿元",
    "href": "http://stock.jrj.com.cn/2020/01/22192628722395.shtml",
    "datetime": "2020-01-22 19:26:20",
    "code": "002198"
  },
  {
    "title": "嘉应制药：公司取得《药品GMP证书》",
    "href": "http://stock.jrj.com.cn/2019/11/29162828468844.shtml",
    "datetime": "2019-11-29 16:28:20",
    "code": "002198"
  },
  {
    "title": "嘉应制药：取得药品GMP证书",
    "href": "http://stock.jrj.com.cn/2019/11/29161328468768.shtml",
    "datetime": "2019-11-29 16:13:18",
    "code": "002198"
  },
  {
    "title": "嘉应制药：取得《药品GMP证书》",
    "href": "http://stock.jrj.com.cn/2019/11/29160328468753.shtml",
    "datetime": "2019-11-29 16:03:00",
    "code": "002198"
  },
  {
    "title": "3日公司新闻聚焦：格力易主迎来终极战 嘉应制药弃购德昌祥",
    "href": "http://stock.jrj.com.cn/2019/09/03091928081356.shtml",
    "datetime": "2019-09-03 09:19:00",
    "code": "002198"
  },
  {
    "title": "历时一年半未谈拢 嘉应制药弃购德昌祥",
    "href": "http://stock.jrj.com.cn/2019/09/03041428078184.shtml",
    "datetime": "2019-09-03 04:14:35",
    "code": "002198"
  },
  {
    "title": "嘉应制药筹划一年半的重组告吹 工业大麻光环褪去",
    "href": "http://stock.jrj.com.cn/2019/09/02192728078362.shtml",
    "datetime": "2019-09-02 19:27:43",
    "code": "002198"
  },
  {
    "title": "历时一年半收购预案“难产” 嘉应制药终止收购德昌祥",
    "href": "http://stock.jrj.com.cn/2019/09/02184728077842.shtml",
    "datetime": "2019-09-02 18:47:00",
    "code": "002198"
  },
  {
    "title": "嘉应制药：终止筹划重大资产重组事项，",
    "href": "http://stock.jrj.com.cn/2019/09/02163828076703.shtml",
    "datetime": "2019-09-02 16:38:01",
    "code": "002198"
  },
  {
    "title": "重组标的股权结构“悄然”生变 嘉应制药称不知情",
    "href": "http://stock.jrj.com.cn/2019/08/29175528056950.shtml",
    "datetime": "2019-08-29 17:55:05",
    "code": "002198"
  },
  {
    "title": "嘉应制药：2019年半年度报告主要财务指标",
    "href": "http://stock.jrj.com.cn/2019/08/01205027917312.shtml",
    "datetime": "2019-08-01 20:50:00",
    "code": "002198"
  },
  {
    "title": "嘉应制药：上半年净利1390万元 同比增长22%",
    "href": "http://stock.jrj.com.cn/2019/08/01171427916273.shtml",
    "datetime": "2019-08-01 17:14:48",
    "code": "002198"
  },
  {
    "title": "嘉应制药股东中联集信申请延期实施增持公司股份的计划",
    "href": "http://stock.jrj.com.cn/2019/06/30175127774239.shtml",
    "datetime": "2019-06-30 17:51:23",
    "code": "002198"
  },
  {
    "title": "嘉应制药一季度净利848万同比增长1% 现金流量净额为-2885万元",
    "href": "http://stock.jrj.com.cn/2019/04/26070327488775.shtml",
    "datetime": "2019-04-26 07:03:52",
    "code": "002198"
  },
  {
    "title": "重组对象收购工业大麻企业 嘉应制药股价连涨",
    "href": "http://stock.jrj.com.cn/2019/04/17183627417013.shtml",
    "datetime": "2019-04-17 18:36:25",
    "code": "002198"
  },
  {
    "title": "重组标的涉足工业大麻 嘉应制药连续两日涨停",
    "href": "http://stock.jrj.com.cn/2019/04/17100427414269.shtml",
    "datetime": "2019-04-17 10:04:26",
    "code": "002198"
  },
  {
    "title": "嘉应制药重组标的涉足工业大麻",
    "href": "http://stock.jrj.com.cn/2019/04/14234227396449.shtml",
    "datetime": "2019-04-14 23:42:43",
    "code": "002198"
  },
  {
    "title": "嘉应制药股东信托计划减持716万股 套现约5988万元",
    "href": "http://stock.jrj.com.cn/2019/03/28084927256315.shtml",
    "datetime": "2019-03-28 08:49:02",
    "code": "002198"
  },
  {
    "title": "嘉应制药股东中联集信增持进展：期限过半 完成3%",
    "href": "http://stock.jrj.com.cn/2019/02/18102827054532.shtml",
    "datetime": "2019-02-18 10:28:57",
    "code": "002198"
  },
  {
    "title": "去年业绩预告与实际存较大差异 嘉应制药时任高管收警示函",
    "href": "http://stock.jrj.com.cn/2018/11/08225125320412.shtml",
    "datetime": "2018-11-08 22:51:44",
    "code": "002198"
  },
  {
    "title": "嘉应制药信披违规 收到广东证监局警示函",
    "href": "http://stock.jrj.com.cn/2018/11/08162025319159.shtml",
    "datetime": "2018-11-08 16:20:13",
    "code": "002198"
  },
  {
    "title": "预计赚3400万实际亏2个多亿 证监会对嘉应制药的“糊涂账”开罚单",
    "href": "http://stock.jrj.com.cn/2018/11/08160925319153.shtml",
    "datetime": "2018-11-08 16:09:00",
    "code": "002198"
  },
  {
    "title": "嘉应制药：信披违规 收到广东证监局警示函",
    "href": "http://stock.jrj.com.cn/2018/11/08155225319081.shtml",
    "datetime": "2018-11-08 15:52:00",
    "code": "002198"
  },
  {
    "title": "嘉应制药：2018年年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2018/10/22181025238763.shtml",
    "datetime": "2018-10-22 18:10:00",
    "code": "002198"
  },
  {
    "title": "嘉应制药：2018年前三季度报告主要财务指标",
    "href": "http://stock.jrj.com.cn/2018/10/22164025238287.shtml",
    "datetime": "2018-10-22 16:40:00",
    "code": "002198"
  },
  {
    "title": "净利润多亏损1.5亿元 嘉应制药及相关当事人为“财务造假”买单",
    "href": "http://stock.jrj.com.cn/2018/10/08134225169481.shtml",
    "datetime": "2018-10-08 13:42:00",
    "code": "002198"
  },
  {
    "title": "中联集信成第一大股东 嘉应制药涨停",
    "href": "http://stock.jrj.com.cn/2018/07/26094924865460.shtml",
    "datetime": "2018-07-26 09:49:42",
    "code": "002198"
  },
  {
    "title": "嘉应制药：中联集信成第一大股东 拟增持至少5%股份",
    "href": "http://stock.jrj.com.cn/2018/07/25205124863551.shtml",
    "datetime": "2018-07-25 20:51:24",
    "code": "002198"
  },
  {
    "title": "嘉应制药：中联集信成公司第一大股东 拟增持不低于5%股份",
    "href": "http://stock.jrj.com.cn/2018/07/25204524863528.shtml",
    "datetime": "2018-07-25 20:45:00",
    "code": "002198"
  },
  {
    "title": "嘉应制药：接骨七厘片等药品配方若改变 将增加子公司成本",
    "href": "http://stock.jrj.com.cn/2018/06/28163024741599.shtml",
    "datetime": "2018-06-28 16:30:00",
    "code": "002198"
  },
  {
    "title": "嘉应制药放天量“撬板” 一线游资现身",
    "href": "http://stock.jrj.com.cn/2018/05/27072924594813.shtml",
    "datetime": "2018-05-27 07:29:09",
    "code": "002198"
  },
  {
    "title": "嘉应制药第5个跌停打开 深圳老虎汇资管浮亏7亿元",
    "href": "http://stock.jrj.com.cn/2018/05/25105524590064.shtml",
    "datetime": "2018-05-25 10:55:00",
    "code": "002198"
  },
  {
    "title": "嘉应制药：复牌继续推进重组事项",
    "href": "http://stock.jrj.com.cn/hotstock/2018/05/22075924571929.shtml",
    "datetime": "2018-05-22 07:59:59",
    "code": "002198"
  },
  {
    "title": "嘉应制药：与德昌祥药业签署战略合作框架协议",
    "href": "http://stock.jrj.com.cn/hotstock/2018/05/22075924571932.shtml",
    "datetime": "2018-05-22 07:59:59",
    "code": "002198"
  },
  {
    "title": "嘉应制药：关于股票复牌且继续推进重大资产重组事项的公告",
    "href": "http://stock.jrj.com.cn/2018/05/21203024569981.shtml",
    "datetime": "2018-05-21 20:30:00",
    "code": "002198"
  },
  {
    "title": "嘉应制药：明日复牌 继续推进重组事项",
    "href": "http://stock.jrj.com.cn/2018/05/21190524569694.shtml",
    "datetime": "2018-05-21 19:05:00",
    "code": "002198"
  },
  {
    "title": "嘉应制药大股东股份被冻结",
    "href": "http://stock.jrj.com.cn/2018/05/02031624476080.shtml",
    "datetime": "2018-05-02 03:16:17",
    "code": "002198"
  },
  {
    "title": "嘉应制药3年净利遭吞噬",
    "href": "http://stock.jrj.com.cn/2018/04/26041924452750.shtml",
    "datetime": "2018-04-26 04:19:16",
    "code": "002198"
  },
  {
    "title": "嘉应制药：2018年半年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2018/04/25173024450833.shtml",
    "datetime": "2018-04-25 17:30:00",
    "code": "002198"
  },
  {
    "title": "嘉应制药10年首亏 昔日“摇钱树”反噬三年净利",
    "href": "http://stock.jrj.com.cn/2018/04/25152924449946.shtml",
    "datetime": "2018-04-25 15:29:35",
    "code": "002198"
  },
  {
    "title": "监管收紧 商誉总额增速放缓",
    "href": "http://stock.jrj.com.cn/2018/03/06040424195360.shtml",
    "datetime": "2018-03-06 04:04:15",
    "code": "002198"
  },
  {
    "title": "商誉减值近亿 嘉应制药10年首亏",
    "href": "http://stock.jrj.com.cn/2018/02/27082824160027.shtml",
    "datetime": "2018-02-27 08:28:24",
    "code": "002198"
  },
  {
    "title": "嘉应制药拟披露重大事项临停",
    "href": "http://stock.jrj.com.cn/2018/02/22093224134398.shtml",
    "datetime": "2018-02-22 09:32:31",
    "code": "002198"
  },
  {
    "title": "午间公告：嘉应制药大股东筹划股份转让 控制权或变更",
    "href": "http://stock.jrj.com.cn/2018/01/31120524037378.shtml",
    "datetime": "2018-01-31 12:05:00",
    "code": "002198"
  },
  {
    "title": "嘉应制药：2017年年度业绩报告预告(修正公告)",
    "href": "http://stock.jrj.com.cn/2018/01/30171024031893.shtml",
    "datetime": "2018-01-30 17:10:01",
    "code": "002198"
  },
  {
    "title": "3年盈利未分红遭问询 嘉应制药称已反思并提分配预案",
    "href": "http://stock.jrj.com.cn/2017/09/08022723079663.shtml",
    "datetime": "2017-09-08 02:27:52",
    "code": "002198"
  },
  {
    "title": "三年盈利未分红遭问询 嘉应制药称已反思并提分配预案",
    "href": "http://stock.jrj.com.cn/2017/09/07233923079315.shtml",
    "datetime": "2017-09-07 23:39:59",
    "code": "002198"
  },
  {
    "title": "三年盈利不分红 嘉应制药遭交易所问询",
    "href": "http://stock.jrj.com.cn/2017/08/29052723018292.shtml",
    "datetime": "2017-08-29 05:27:47",
    "code": "002198"
  },
  {
    "title": "“老虎”不松口的嘉应制药真有那么香？",
    "href": "http://stock.jrj.com.cn/2017/06/27010622658410.shtml",
    "datetime": "2017-06-27 01:06:36",
    "code": "002198"
  },
  {
    "title": "嘉应制药、合纵科技、滨江集团获重要股东增持",
    "href": "http://stock.jrj.com.cn/2017/06/08181522588793.shtml",
    "datetime": "2017-06-08 18:15:08",
    "code": "002198"
  },
  {
    "title": "一致行动人“结盟”成实控人 嘉应制药收深交所关注函",
    "href": "http://stock.jrj.com.cn/2017/05/03031822417182.shtml",
    "datetime": "2017-05-03 03:18:20",
    "code": "002198"
  },
  {
    "title": "嘉应制药两董事未确认年报真实性引交易所关注",
    "href": "http://stock.jrj.com.cn/2017/04/17131022327688.shtml",
    "datetime": "2017-04-17 13:10:49",
    "code": "002198"
  },
  {
    "title": "嘉应制药10股东抱团结盟抗衡“野蛮人”",
    "href": "http://stock.jrj.com.cn/2017/04/13015922305792.shtml",
    "datetime": "2017-04-13 01:59:33",
    "code": "002198"
  },
  {
    "title": "杠杆式收购嘉应制药 上市公司质疑第一大股东重组能力",
    "href": "http://stock.jrj.com.cn/2017/01/18025721979849.shtml",
    "datetime": "2017-01-18 02:57:06",
    "code": "002198"
  },
  {
    "title": "新东家老虎汇“一厢情愿” 嘉应制药否认已入“虎口”",
    "href": "http://stock.jrj.com.cn/2016/12/28032021896248.shtml",
    "datetime": "2016-12-28 03:20:04",
    "code": "002198"
  },
  {
    "title": "海南椰岛董事长染指嘉应制药 将进一步增持",
    "href": "http://stock.jrj.com.cn/2016/12/05092921791115.shtml",
    "datetime": "2016-12-05 09:29:50",
    "code": "002198"
  },
  {
    "title": "嘉应制药控股股东筹划转让控股权 21日起停牌",
    "href": "http://stock.jrj.com.cn/2016/11/21120121732911.shtml",
    "datetime": "2016-11-21 12:01:59",
    "code": "002198"
  },
  {
    "title": "嘉应制药股东黄智勇持股比例由9.55％降至4.93％",
    "href": "http://stock.jrj.com.cn/2016/08/24171021364102.shtml",
    "datetime": "2016-08-24 17:10:44",
    "code": "002198"
  },
  {
    "title": "盛屯矿业中报拟10转15派0.5 嘉应制药中期净利增超3倍",
    "href": "http://stock.jrj.com.cn/2014/07/30070317703010.shtml",
    "datetime": "2014-07-30 07:03:36",
    "code": "002198"
  },
  {
    "title": "嘉应制药与暨南大学合作研发“抗肿瘤纳米药物”",
    "href": "http://stock.jrj.com.cn/2014/04/10210717020859.shtml",
    "datetime": "2014-04-10 21:07:00",
    "code": "002198"
  },
  {
    "title": "嘉应制药财务总监周书英辞职",
    "href": "http://stock.jrj.com.cn/2014/03/05115016800465.shtml",
    "datetime": "2014-03-05 11:50:00",
    "code": "002198"
  },
  {
    "title": "嘉应制药受让华清园生物45％股权",
    "href": "http://stock.jrj.com.cn/2014/01/01192116427502.shtml",
    "datetime": "2014-01-01 19:21:00",
    "code": "002198"
  },
  {
    "title": "嘉应制药“蛇吞象”式收购获核准 耗资4亿拿下金沙药业",
    "href": "http://stock.jrj.com.cn/2013/10/28012016033491.shtml",
    "datetime": "2013-10-28 01:20:03",
    "code": "002198"
  },
  {
    "title": "嘉应制药成功收购金沙药业 市场静待整合推进",
    "href": "http://stock.jrj.com.cn/2013/10/25152216028650.shtml",
    "datetime": "2013-10-25 15:22:28",
    "code": "002198"
  },
  {
    "title": "三季报黑马奔腾：嘉应制药净利润同比大涨1530%",
    "href": "http://stock.jrj.com.cn/hotstock/2013/10/16075615968609.shtml",
    "datetime": "2013-10-16 07:56:12",
    "code": "002198"
  },
  {
    "title": "三季报黑马奔腾 嘉应制药净利润同比大涨1530%",
    "href": "http://stock.jrj.com.cn/2013/10/16033415967456.shtml",
    "datetime": "2013-10-16 03:34:36",
    "code": "002198"
  },
  {
    "title": "嘉应制药前三季盈利增长超15倍",
    "href": "http://stock.jrj.com.cn/2013/10/16004015966791.shtml",
    "datetime": "2013-10-16 00:40:18",
    "code": "002198"
  },
  {
    "title": "证监会恢复审核嘉应制药并购重组申请",
    "href": "http://stock.jrj.com.cn/2013/08/16223115698734.shtml",
    "datetime": "2013-08-16 22:31:38",
    "code": "002198"
  },
  {
    "title": "118家公司抢发三季报预告 嘉应制药业绩暴增10倍拔头筹",
    "href": "http://stock.jrj.com.cn/2013/08/08055315650830.shtml",
    "datetime": "2013-08-08 05:53:49",
    "code": "002198"
  },
  {
    "title": "嘉应制药中期净利737万 同比扭亏",
    "href": "http://stock.jrj.com.cn/2013/07/24202015580324.shtml",
    "datetime": "2013-07-24 20:20:00",
    "code": "002198"
  },
  {
    "title": "嘉应制药揽“金沙”入怀 期待1+1＞2",
    "href": "http://stock.jrj.com.cn/2013/05/03100715273182.shtml",
    "datetime": "2013-05-03 10:07:57",
    "code": "002198"
  },
  {
    "title": "销量增长较大 嘉应制药上修一季度业绩预告",
    "href": "http://stock.jrj.com.cn/2013/04/12213315224087.shtml",
    "datetime": "2013-04-12 21:33:53",
    "code": "002198"
  },
  {
    "title": "嘉应制药上市5年原地踏步走 定增资产瓶颈期",
    "href": "http://stock.jrj.com.cn/2013/02/25065815081860.shtml",
    "datetime": "2013-02-25 06:58:00",
    "code": "002198"
  },
  {
    "title": "嘉应制药：定增收购金沙药业64%股权",
    "href": "http://stock.jrj.com.cn/hotstock/2013/02/18081915061556.shtml",
    "datetime": "2013-02-18 08:19:59",
    "code": "002198"
  },
  {
    "title": "上工申贝、嘉应制药齐推定增预案",
    "href": "http://stock.jrj.com.cn/2013/02/18071615061258.shtml",
    "datetime": "2013-02-18 07:16:33",
    "code": "002198"
  },
  {
    "title": "嘉应制药明起停牌 筹划重大重组",
    "href": "http://stock.jrj.com.cn/2013/01/15195614946883.shtml",
    "datetime": "2013-01-15 19:56:48",
    "code": "002198"
  },
  {
    "title": "嘉应制药：终止筹划重组",
    "href": "http://stock.jrj.com.cn/2012/03/19091712518508.shtml",
    "datetime": "2012-03-19 09:17:41",
    "code": "002198"
  },
  {
    "title": "嘉应制药大股东减持480万股 占总股本2.3%",
    "href": "http://stock.jrj.com.cn/2011/06/28203210317294.shtml",
    "datetime": "2011-06-28 20:32:07",
    "code": "002198"
  },
  {
    "title": "嘉应制药实际控制人将在半年内减持超5%股份",
    "href": "http://stock.jrj.com.cn/2011/06/10071410169179.shtml",
    "datetime": "2011-06-10 07:14:24",
    "code": "002198"
  },
  {
    "title": "嘉应制药控股股东拟减持公司股份",
    "href": "http://stock.jrj.com.cn/2011/05/1710139983824.shtml",
    "datetime": "2011-05-17 10:13:27",
    "code": "002198"
  },
  {
    "title": "嘉应制药:一股东因个人理财需要减持近5%股份",
    "href": "http://stock.jrj.com.cn/2011/03/2309469537046.shtml",
    "datetime": "2011-03-23 09:46:22",
    "code": "002198"
  },
  {
    "title": "嘉应制药股东减持809万股",
    "href": "http://stock.jrj.com.cn/2011/03/2308469536082.shtml",
    "datetime": "2011-03-23 08:46:21",
    "code": "002198"
  }
]